Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$6.80
-6.1%		$8.62
$5.37
▼
$17.58
$457.24M1.781.00 million shs1.45 million shs
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$1.32
-5.0%		$1.20
$0.64
▼
$1.87
$141.40M1.48925,612 shs1.00 million shs
OmniAb, Inc. stock logo
OABI
OmniAb
$3.38
-1.5%		$2.35
$1.30
▼
$3.63
$489.37M0.45646,012 shs553,941 shs
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$7.29
-1.2%		$5.43
$1.91
▼
$7.84
$390.85M0.64184,628 shs552,673 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-5.91%-14.56%-24.62%-11.67%-49.16%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-5.04%+11.86%-7.04%+26.92%-4.35%
OmniAb, Inc. stock logo
OABI
OmniAb
-1.46%+9.74%+62.50%+55.05%+64.88%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-1.22%+12.85%+37.81%+107.69%+49.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$6.80
-6.1%		$8.62
$5.37
▼
$17.58
$457.24M1.781.00 million shs1.45 million shs
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$1.32
-5.0%		$1.20
$0.64
▼
$1.87
$141.40M1.48925,612 shs1.00 million shs
OmniAb, Inc. stock logo
OABI
OmniAb
$3.38
-1.5%		$2.35
$1.30
▼
$3.63
$489.37M0.45646,012 shs553,941 shs
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$7.29
-1.2%		$5.43
$1.91
▼
$7.84
$390.85M0.64184,628 shs552,673 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-5.91%-14.56%-24.62%-11.67%-49.16%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-5.04%+11.86%-7.04%+26.92%-4.35%
OmniAb, Inc. stock logo
OABI
OmniAb
-1.46%+9.74%+62.50%+55.05%+64.88%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-1.22%+12.85%+37.81%+107.69%+49.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
1.33
Sell$7.002.99% Upside
MaxCyte, Inc. stock logo
MXCT
MaxCyte
2.00
Hold$5.00278.79% Upside
OmniAb, Inc. stock logo
OABI
OmniAb
2.00
HoldN/AN/A
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
2.25
Hold$7.502.88% Upside

Current Analyst Ratings Breakdown

Latest MXCT, OABI, DNA, and TKNO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2026
MaxCyte, Inc. stock logo
MXCT
MaxCyte
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/11/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/11/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Buy$8.00
8/7/2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$12.00 ➝ $9.00
8/6/2026
OmniAb, Inc. stock logo
OABI
OmniAb
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/6/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
8/5/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$7.00
8/5/2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$7.00
7/28/2026
MaxCyte, Inc. stock logo
MXCT
MaxCyte
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/21/2026
OmniAb, Inc. stock logo
OABI
OmniAb
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/17/2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$170.15M2.69N/AN/A$6.24 per share1.09
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$33.03M4.28N/AN/A$1.61 per share0.82
OmniAb, Inc. stock logo
OABI
OmniAb
$38.46M12.73N/AN/A$1.80 per share1.88
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
$40.52M9.65N/AN/A$1.17 per share6.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$312.76M-$5.01N/AN/AN/A-259.96%-60.27%-26.88%N/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$44.63M-$0.33N/AN/AN/A-114.77%-18.52%-15.77%N/A
OmniAb, Inc. stock logo
OABI
OmniAb
-$64.78M-$0.36N/AN/AN/A-115.12%-16.59%-14.82%11/3/2026 (Estimated)
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-$17.26M-$0.31N/AN/AN/A-38.37%-24.94%-16.53%N/A

Latest MXCT, OABI, DNA, and TKNO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$0.09-$0.08+$0.01-$0.08$6.51 million$6.50 million
8/6/2026Q2 2026
OmniAb, Inc. stock logo
OABI
OmniAb
-$0.12-$0.05+$0.07-$0.05$4.69 million$13.42 million
8/5/2026Q2 2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$0.8950-$0.75+$0.1450-$0.75$24.05 million$20.16 million
8/5/2026Q2 2026
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
-$0.0843-$0.06+$0.0243-$0.06$10.95 million$12.19 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/AN/AN/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/AN/AN/AN/AN/A
OmniAb, Inc. stock logo
OABI
OmniAb
N/AN/AN/AN/AN/A
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/A
4.57
4.57
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/A
12.04
11.29
OmniAb, Inc. stock logo
OABI
OmniAb
N/A
4.80
4.80
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
0.21
4.49
3.48

Institutional Ownership

CompanyInstitutional Ownership
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
78.63%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
68.81%
OmniAb, Inc. stock logo
OABI
OmniAb
72.08%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
13.81%

Insider Ownership

CompanyInsider Ownership
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
12.69%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
4.10%
OmniAb, Inc. stock logo
OABI
OmniAb
9.80%
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
13.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
64067.34 million58.80 millionOptionable
MaxCyte, Inc. stock logo
MXCT
MaxCyte
80107.12 million102.73 millionOptionable
OmniAb, Inc. stock logo
OABI
OmniAb
7144.78 million130.59 millionOptionable
Alpha Teknova, Inc. stock logo
TKNO
Alpha Teknova
24053.61 million46.54 millionNot Optionable

Recent News About These Companies

Wall Street Analysts Believe Alpha Teknova (TKNO) Could Rally 35.45%: Here's is How to Trade
August 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2971883/wall-street-analysts-believe-alpha-teknova-tkno-could-rally-35-45-here-s-is-how-to-trade?cid=cs-stocknewsapi-ft-fundamental_analysis|consensus_price_target-2971883
Alpha Teknova (NASDAQ:TKNO) Raised to Hold at Zacks Research
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-raised-to-hold-at-zacks-research-2026-08-08/
Alpha Teknova (NASDAQ:TKNO) Research Coverage Started at Roth Capital
August 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30948195
Alpha Teknova (NASDAQ:TKNO) Upgraded to "Buy" at Wall Street Zen
August 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30947508
Alpha Teknova (NASDAQ:TKNO) Upgraded at Wall Street Zen
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-upgraded-at-wall-street-zen-2026-08-08/
Alpha Teknova (TKNO) Stock Moves Higher on Booming Clinical Demand
August 7, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/alpha-teknova-tkno-stock-moves-higher-on-booming-clinical-demand-1807999/
Teknova targets less than $8M 2026 free cash outflow as it lifts revenue guide to $45M-$47M
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4627100-teknova-targets-less-than-8m-2026-free-cash-outflow-as-it-lifts-revenue-guide-to-45m-47m
Roth Capital Upgrades Alpha Teknova (NASDAQ:TKNO) to Strong-Buy
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/roth-capital-upgrades-alpha-teknova-nasdaqtkno-to-strong-buy-2026-08-06/
Alpha Teknova Q2 Earnings Call Highlights
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-q2-earnings-call-highlights-2026-08-06/
Alpha Teknova (NASDAQ:TKNO) Issues Earnings Results, Beats Estimates By $0.02 EPS
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-issues-earnings-results-beats-estimates-by-002-eps-2026-08-05/
Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
August 5, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/teknova-launches-build-tek-a-proprietary-ai-reagent-assistant-that-allows-customers-to-configure-complex-custom-product-requests-in-minutes-1036413072
Teknova Reports Second Quarter 2026 Financial Results
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339649/0/en/teknova-reports-second-quarter-2026-financial-results.html
Alpha Teknova (TKNO) to Release Quarterly Earnings on Wednesday
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-tkno-to-release-quarterly-earnings-on-wednesday-2026-07-29/
Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/22/3331688/0/en/teknova-to-report-second-quarter-2026-financial-results-on-august-5-2026.html
Alpha Teknova, Inc. $TKNO Holdings Boosted by Roubaix Capital LLC
July 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-alpha-teknova-inc-tkno-holdings-boosted-by-roubaix-capital-llc-2026-07-19/
Alpha Teknova (NASDAQ:TKNO) Shares Down 2.2% - What's Next?
July 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alpha-teknova-nasdaqtkno-shares-down-22-whats-next-2026-07-16/
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Arcus Biosciences (RCUS) and Tenaya Therapeutics (TNYA)
June 4, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2309178/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-arcus-biosciences-rcus-and-tenaya-therapeutics-tnya/
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and REPRO-MED Systems (KRMD)
May 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TKNO/pressreleases/1763703/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-and-repro-med-systems-krmd/
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/alpha-teknova-inc-nasdaq-tkno-142331465.html
Alpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call Transcript
May 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4901691-alpha-teknova-inc-tkno-q1-2026-earnings-call-transcript
Alpha Teknova Charts Cautious Path to 2027 Growth
May 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/alpha-teknova-charts-cautious-path-to-2027-growth?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

Ginkgo Bioworks stock logo

Ginkgo Bioworks NYSE:DNA

$6.80 -0.44 (-6.12%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$6.81 +0.02 (+0.22%)
As of 08/14/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

MaxCyte stock logo

MaxCyte NASDAQ:MXCT

$1.32 -0.07 (-5.04%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$1.32 +0.00 (+0.38%)
As of 08/14/2026 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

OmniAb stock logo

OmniAb NASDAQ:OABI

$3.38 -0.05 (-1.46%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$3.32 -0.06 (-1.78%)
As of 08/14/2026 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

Alpha Teknova stock logo

Alpha Teknova NASDAQ:TKNO

$7.29 -0.09 (-1.22%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$7.35 +0.06 (+0.78%)
As of 08/14/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas